Treatment effect modifiers for individuals with acute low back pain: secondary analysis of the TARGET trial.

Journal Article (Journal Article)

ABSTRACT: Treatment effect modifiers identify patient characteristics associated with treatment responses. The purpose of this secondary analysis was to identify potential treatment effect modifiers for disability from the TARGET trial that compared usual care (control) to usual care + psychologically informed physical therapy (PIPT). The sample consisted of STarT Back tool identified high risk patients with acute low back pain that completed Oswestry Disability Index (ODI) data at index visit and 6 months later (n = 1,250). Candidate treatment effect modifiers were identified a-priori and informed by literature. Linear mixed models tested for treatment effect modification through tests of statistical interaction. All statistical interactions (P ≤ 0.20) were stratified by modifier to inspect for specific effects (P ≤ 0.05). Smoking was identified as a potential effect modifier (treatment*smoking interaction, P = 0.08). In participants who were smokers, the effect of PIPT was (ODI = 5.5; 95% CI: 0.6 - 10.4; P = 0.03) compared to usual care. In participants who were non-smokers, the effect of PIPT was (ODI = 1.5; 95% CI: -1.4 - 4.4; P = 0.31) compared to usual care. Pain medication was also identified as a potential effect modifier (treatment*pain medication interaction, P = 0.10). In participants prescribed ≥3 pain medications, the effect of PIPT was (ODI = 7.1; 95% CI: -0.1 - 14.2; P = 0.05) compared to usual care. The effect of PIPT for participants prescribed no pain medication was (ODI = 3.5; 95% CI: -0.4 - 7.4; P = 0.08) and for participants prescribed 1-2 pain medications was (ODI = 0.6; 95% CI: -2.5 - 3.7; P = 0.70) when compared to usual care. These findings may be used for generating hypotheses and/or planning future clinical trials investigating the effectiveness of tailored application of PIPT.

Full Text

Duke Authors

Cited Authors

  • Beneciuk, JM; George, SZ; Patterson, CG; Smith, CN; Brennan, GP; Wegener, ST; Roseen, EJ; Saper, RB; Delitto, A

Published Date

  • May 9, 2022

Published In

PubMed ID

  • 35543647

Electronic International Standard Serial Number (EISSN)

  • 1872-6623

Digital Object Identifier (DOI)

  • 10.1097/j.pain.0000000000002679


  • eng

Conference Location

  • United States